Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
326.40    -9.00 (-2.68%)
Bid:
326.60
Ask:
327.40
Spread: 0.80 (0.245%)
Market Cap: £715.04m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Director/PDMR Shareholding

31 Mar 2021 10:00

RNS Number : 1061U
Burford Capital Limited
31 March 2021
 

 

31 March 2021

 

 

BURFORD CAPITAL LIMITED

 

Notification of Transactions by Persons Discharging Managerial Responsibilities

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, has been notified of certain share purchases made by Christopher Bogart, Burford's Chief Executive Officer, and Jonathan Molot, Burford's Chief Investment Officer, as part of their broader acquisition of shares as detailed in Burford's 2020 Annual Report.

 

On March 26, 2021, Mr Bogart and Mr Molot each purchased a total of 2,000 shares of Burford on the New York Stock Exchange at an average price of $8.23 per share. On March 29, 2021, Mr Bogart and Mr Molot each purchased a total of 2,566 shares at an average price of $8.30 per share. On March 30, 2021, Mr Bogart and Mr Molot each purchased a total of 901 shares at an average price of $8.49 per share.

 

As a result of these transactions, Mr Bogart controls a total of 9,042,344 shares and Mr Molot controls a total of 9,655,467 shares.

 

The Notification of Dealing Forms for each of the transactions mentioned above are included at the end of this announcement.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Kevin Cruickshank (NOMAD)

Charlie Farquhar / Jonathan Abbott (Joint Broker)

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information, please visit www.burfordcapital.com.

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934 regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with the US Securities and Exchange Commission, other information sent to our security holders, and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that our actual results of operations, including our financial condition and liquidity and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this report. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 24, 2021. In addition, even if our results of operations, including our financial condition and liquidity and the development of the industry in which we operate, are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this report, whether as a result of new information, future events, a change in our views or expectations or otherwise.

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Christopher Bogart

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Executive Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Purchase of Ordinary Shares

(c) Price(s)and volume(s)

Price(s)

Volume(s)

(i) $8.2329

(ii) $8.30

(iii) $8.4944

2,000

2,566

901

(d) Aggregated information

· Aggregated volume

· Price

$45,417.05 5,467

(e) Date of the transaction

(i) March 26, 2021

(ii) March 29, 2021

(iii) March 30, 2021

 

(f) Place of the transaction

New York Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Jonathan Molot

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Investment Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Purchase of Ordinary Shares

(c) Price(s)and volume(s)

Price(s)

Volume(s)

(i) $8.2329

(ii) $8.30

(iii) $8.4944

2,000

2,566

901

(d) Aggregated information

· Aggregated volume

· Price

$45,417.05 5,467

(e) Date of the transaction

(i) March 26, 2021

(ii) March 29, 2021

(iii) March 30, 2021

(f) Place of the transaction

New York Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVFLBXFXLLBBB
Date   Source Headline
1st Jul 20255:46 pmRNSUS Budget Bill Adopted Without Lit Fin Provisions
1st Jul 20257:15 amRNSUpdate Re US Budget Bill and YPF Ruling
30th Jun 20258:00 amRNSFurther Statement Re US Budget Reconciliation Bill
30th Jun 20257:00 amRNSChange of Nominated Adviser
17th Jun 20257:00 amRNSStatement Re US Budget Reconciliation Bill
10th Jun 20251:00 pmRNSIssue of Equity & Director/PDMR Shareholding
6th Jun 202511:30 amRNSCompleted Purchases of Shares
5th Jun 20251:00 pmRNSIntended Purchases of Ordinary Shares
30th May 202512:00 pmRNSSterling FX Rate for 2024 Final Dividend
16th May 20251:30 pmRNSDirector/PDMR Shareholding
15th May 20251:00 pmRNSResult of AGM
14th May 202512:37 pmRNSMSCI Change to BUR Index Country Classification
7th May 20251:00 pmRNS1Q25 Financial Results
6th May 202512:00 pmRNSNotice of Retail Shareholder Audio Webcast
30th Apr 202512:00 pmRNSNotice of 1Q25 Results & Results Call Details
28th Apr 202512:00 pmRNSAdditional Definitive Proxy Soliciting Materials
10th Apr 202512:00 pmRNSIssue of Equity & Director/PDMR Shareholding
4th Apr 20257:00 amRNSDefinitive Proxy Materials and 2024 Annual Report
3rd Apr 202512:00 pmRNSStrategic Update at 2025 Investor Day
17th Mar 202511:00 amRNSPartial Repurchase and Cancellation of Bonds
17th Mar 202511:00 amRNSIntended Purchases of Ordinary Shares
11th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSFiling of 2024 Annual Report on Form 10-K
3rd Mar 202512:00 pmRNSAnnual Results for Year Ended December 31, 2024
25th Feb 20257:00 amRNSNotice of 2024 Results & Reporting Change Preview
4th Feb 20252:00 pmRNSBurford Capital announces 2025 Investor Day
31st Jan 20257:30 amRNSDirector/PDMR Shareholding
27th Dec 202411:00 amRNSIssue of New Shares in Connection With LTIP
17th Dec 202411:00 amRNSDirector/PDMR Shareholding
22nd Nov 202412:00 pmRNSDirector/PDMR Shareholding
15th Nov 20241:15 pmRNSPartial Repurchase and Cancellation of Bonds
8th Nov 202412:00 pmRNSSterling Conversion Rate for 2024 Interim Dividend
7th Nov 202412:46 pmRNS3Q24 Results & Quarterly Report
7th Nov 202412:03 pmRNSBurford Statement re YPF Matter
28th Oct 202412:00 pmRNSNotice of 3Q24 Results & Results Call Details
17th Oct 202411:00 amRNS2025 AGM Logistics
1st Oct 202411:00 amRNSDirector/PDMR Shareholding
25th Sep 20241:15 pmRNSIssue of New Shares in Connection With LTIP
23rd Aug 202412:00 pmRNSResult of Meeting
23rd Aug 202411:30 amRNSDirector/PDMR Shareholding
21st Aug 202411:00 amRNSDirector/PDMR Shareholding
8th Aug 202412:00 pmRNS2Q24 Results & Quarterly Report
5th Aug 202412:00 pmRNSTransition to US Domestic Issuer Status
31st Jul 202412:00 pmRNSNotice of 2Q24 Results & Results Call Details
22nd Jul 202412:00 pmRNSNotice of EGM
10th Jul 20247:00 amRNSAppointment of KPMG LLP as Independent Auditor
2nd Jul 202411:00 amRNSHolding(s) in Company
28th Jun 202412:00 pmRNSIssue of New Shares for LTIP & Adjusted PDMR LTIP
21st Jun 20241:00 pmRNSIssue of New Shares Pursuant to DCP & PDMR Notices
6th Jun 20241:30 pmRNSPartial Repurchase and Cancellation of Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.